VRAX

Virax Biolabs Group Limited VRAX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VRAX WINT NCEL MLEC DRMA GTBP ATXI NKGN ARTL XRTX
6M -50.91 % -92.98 % -89.21 % -95.18 % 216.66 % -75.18 % 118.21 % -80.00 % -72.79 % -31.26 %
YTD -82.36 % -99.76 % -88.07 % -96.03 % 53.96 % -74.26 % -66.22 % -92.76 % -75.99 % -48.72 %
1Y -79.70 % -99.75 % -86.87 % -95.94 % 73.98 % -73.06 % -63.78 % -92.22 % -72.74 % -46.43 %
3Y -93.22 % -100.00 % -99.48 % -96.55 % -94.99 % -97.75 % -99.34 % -99.12 % -91.28 % -90.87 %
5Y -99.79 % -100.00 % -99.78 % -96.68 % -99.83 % -99.70 % -99.99 % -99.12 % -97.20 % -97.88 %
10Y -99.79 % -100.00 % -99.78 % -96.68 % -99.83 % -100.00 % -99.99 % -99.12 % -99.62 % -97.88 %
From the beginning -99.79 % -100.00 % -99.78 % -96.68 % -99.83 % -100.00 % -99.99 % -99.12 % -99.62 % -97.88 %

Dividend

XORTX Therapeutics Inc.